One sentence summary: Expression of a eukaryotic decarboxylase in a yeast strain with an engineered shikimic acid pathway improves the sustainable production of cis, cis-muconic acid.
INTRODUCTION
Aromatic compounds and their derivatives have a wide range of applications, from pharmaceuticals to bulk and fine chemicals. Today, their production relies mainly on the use of fossil resources. As the supply of fossil resources will become sparse, an environmentally sustainable production from renewable feedstocks becomes more and more attractive. Thus, an increasing demand for biotechnological production processes by microbial fermentations has developed. Consequently, the shikimic acid pathway as a major source of aromatic compounds in microbial cells is an important target for metabolic engineering strategies (Suastegui and Sha 2016; Gottardi et al. 2017 ).
Introduction of a feedback resistant variant of 3-deoxy-Darabino-heptulosonate-7-phosphate (DAHP) synthase Aro4 catalyzing the entrance reaction into the shikimic acid pathway, Aro4 K229L , has allowed for the production of even higher CCM titers (Curran et al. 2013; Suastegui et al. , 2017 . Moreover, optimizing the availability of the precursor erythrose-4-phosphate (E4P) has been another strategy to enhance the flux into the shikimic acid pathway (Fig. 1) . Deletion of glucose-6-phosphate dehydrogenase encoded by ZWF1 forces the entry of glycolytic intermediates into the non-oxidative pentose phosphate pathway, which in combination with overexpression of transketolase TKL1 diverts the flux from the glycolytic intermediates fructose-6-phosphate (F6P) and glyceraldehyde-3-phosphate (G3P) to E4P and xylulose-5-phosphate (Curran et al. 2013) . These modifications have permitted the production of high titers of CCM (Curran et al. 2013; Suastegui et al. , 2017 Leavitt et al. 2017) . Despite these achievements, the decarboxylase reaction converting PCA to catechol remains a bottleneck of the established pathway. The activity of AroY could be improved by applying oxygen-limited conditions for culture growth . AroY isomeric subunit C (AroY-C iso ), which contains the decarboxylase function of the enzyme, requires the presence of the cofactor prenylated flavin mononucleotide (prFMN) for its activity (Payer et al. 2017; Weber et al. 2017) . The biosynthesis of this cofactor from FMN is catalyzed by AroY subunit B or, more efficiently, by the endogenous yeast enzyme Pad1. Consequently, the activity of AroY-C could be enhanced by optimizing the cofactor supply (Leavitt et al. 2017; Weber et al. 2017) . In this study, we have successfully utilized a novel class of fungal gallic acid (GA)/PCA decarboxylases for production of CCM in S. cerevisiae. We have developed a strain overexpressing feedback resistant variants of DAHP synthases, Aro3 K222L and Aro4 K229L , together with an Aro1 variant with a mutation in the E-domain, Aro1 K1370A , leading to an enhanced flux into the shikimic acid pathway and allowing for the accumulation of the intermediate 3-DHS. Moreover, the ZWF1 gene was replaced by integration of an expression cassette containing TKL1 under control of the strong, constitutive TDH3 promoter. Expressing the novel decarboxylases in the optimized strain, we could achieve a titer of 1244 mg L −1 and a yield of 31 mg g −1 glucose in a batch fermentation, which represents the highest CCM yield in S. cerevisiae published to date (Table S1 , Supporting Information).
To expand the application of our newly developed strain, we decided to establish the production of GA, a phenolic compound naturally occurring in several plant species. GA has several applications in pharmaceutical and chemical industries and is mainly produced through acid hydrolysis of tannins or biotransformation procedures (Seth and Chand 2000; Bajpai and Patil 2008; Aguilar-Zárate et al. 2015) . These procedures suffer from low yields and low purity and cause environmental pollution. A pathway for production of GA from 3-DHS has already been established in E. coli (Kambourakis, Draths and Frost 2000) . Using P. anserina AroZ and a mutated version of para-hydroxybenzoic acid hydroxylase PobA from Corynebacterium glutamicum with a changed substrate specificity, we were able to demonstrate the production of GA for the first time in S. cerevisiae, reaching a titer of 682 mg L −1 from glucose.
MATERIAL AND METHODS

Strains and media
Yeast strains used in this work are listed in Table 1 . Saccharomyces cerevisiae strains were grown at 30
• C with 180 rpm shaking in synthetic complete (SC) medium (6.7 g L −1 Difco yeast nitrogen base without amino acids), supplemented with amino acids as described previously (Bruder et al. 2016) 
Metabolite analysis
For metabolite analysis, yeast cells were removed from samples by centrifugation. Proteins were precipitated by addition of sulfosalicylic acid to a final concentration of 5%, and concentrations of metabolites were measured by high-performance liquid chromatography (HPLC). The metabolites were separated by HPLC chromatography (Dionex) using a Nucleogel Sugar 810 H column (Macherey-Nagel GmbH & Co, Germany). The column was eluted with 5 mM H 2 SO 4 as mobile phase and a flow rate of 0.6 ml min −1 at the temperature of 65
• C or 57
• C. The detection of glucose was by means of a Shodex RI-101 refractive index detector. A UV detector was used for the detection of PCA (220 nm), catechol (220 nm), GA (220 nm) and CCM (250 nm). For data evaluation, the Chromeleon software (version 6.50) was used.
Plasmid and strain construction
Plasmids and primers used in this study are listed in Tables 2 and  3 . Molecular techniques were performed according to published procedures (Wiedemann and Boles 2008) . Codon-optimized gene versions for increased protein expression in S. cerevisiae were obtained from DNA2.0 (USA) or GeneArt (Germany). Yeast transformations and reisolation of plasmid DNA from yeast cells were carried out as described previously (Boles and Zimmermann 1993; Xiao, Gietz and Woods 2006) . Genes were cloned by homologous recombination. The coding regions of the respective genes were amplified by PCR from genomic DNA or plasmids by using specific primer pairs with 5 -extensions overlapping vector sequences. PCR fragments were co-transformed into yeast together with a linearized vector. Synthetic genes for construction of p426-MET25-TaGDC1 and p426-MET25-MmGDC1 were ordered with 30 base pairs overlap to the MET25 promoter and CYC1 terminator and directly cloned by homologous recombination. All vector encoded genes were controlled by strong promotors (Table 2) . Plasmids were amplified in E. coli strain DH10b (Life Technologies). Escherichia coli transformations were performed via electroporation according to the methods of Dower, Miller and Ragsdale (1988) . Escherichia coli was grown on LB (LuriaBertani) medium with 40 μg ml −1 ampicillin for plasmid selection. Genomic integrations were constructed by using the creloxP-kanMX4-loxP system (Güldener et al. 1996) or using the CRISPR/Cas system (Generoso et al. 2016) . The loxP-kanMX-loxP deletion/integration cassette was PCR amplified from the plasmid pHD8 by using primers binding in the region homologous to the integration site in the PYK2 locus present in the plasmid, allowing homologous recombination. The cassette was transformed into CEN.PK2-1C and selected for geneticin (G418) resistance. The deletion/integration was verified by PCR analysis.
Fermentations and feeding experiments
Cultures of yeast strains (50 ml) were grown in 300 ml shake flasks (Erlenmeyer flasks) at 30
• C in a rotary shaker (180 rpm).
Precultures were grown into the exponential phase in selective SCD media. Cells were washed with sterile water and inoculated to an optical density at 600 nm (OD 600 ) of 0.8 in the same medium. For PCA feeding experiments, cells were inoculated to an OD 600 of 0.8 in selective SCD medium containing If not stated otherwise, cloned genes are under control of promoters and terminators included in the basic vectors. Promoters were taken from 1-500 bps upstream and terminators 1-300 bps downstream of the respective open reading frames, with the exception of the HXT7 promoter (Hamacher et al. 2002) , the MET25 promoter (Mumberg et al. 1994 ) and the ZEO1 promoter (Tochigi et al. 2010) . p, promoter, t, terminator.
5 mM PCA. SCD medium with 5 mM PCA was prepared as follows. PCA was dissolved in distilled water to a concentration of 100 mM and sterile filtered. The stock solution was added to non-buffered, selective SCD medium to a concentration of 5 mM, resulting in a pH of 4.3. Growth/fermentation experiments were performed up to three times by using the same precultures, with the given standard deviations. Samples for the measurement of the OD 600 and the metabolite analyses were taken at different time points.
RESULTS
Improving the flux into the shikimic acid pathway
In order to enhance CCM production, it is important to enhance the substrate flux into the shikimic acid pathway. The two isomeric DAHP synthases Aro3 and Aro4, which catalyze the entrance reaction into the shikimic acid pathway, are known to be feedback inhibited by products of the shikimic acid pathway, tyrosine and phenylalanine, respectively (Braus 1991) . Therefore, we chose to overexpress variants with abolished negative regulation in addition to the natural pathway (Fig. 2) . For Aro4, the mutation K229L is known to lack feedback sensitivity (Hartmann et al. 2003) and has been successfully used in several studies (Curran et al. 2013; McKenna et al. 2014; Li et al. 2015; Rodriguez et al. 2015; . As Aro3 was reported to have a higher affinity for E4P and phosphoenolpyruvate (PEP) compared to Aro4 (Hartmann et al. 2003) , we also created a mutated Aro3 with an analogous K222L point mutation. For comparison, the mutated enzymes or the wild type Aro3 were overexpressed under control of the strong constitutive HXT7 promoter (Hamacher et al. 2002) together with Aro1 lacking the E-domain responsible for conversion of 3-DHS to shikimate (Aro1 E ) in strain CEN.PK2-1C aroE harboring a genomic deletion of the E-domain (Weber et al. 2012 ). This deletion is crucial for the accumulation of the precursor 3-DHS. Additionally, 3-DHS dehydratase AroZ was overexpressed and formation of PCA was measured (Fig. 2) 
Mutation and overexpression of Aro1
In our previous study, the whole E-domain of the pentafunctional enzyme Aro1 was deleted in order to prevent conversion of 3-DHS to shikimate, thereby improving the availability of the CCM pathway substrate 3-DHS (Weber et al. 2012 ). Concerns about possible negative effects on protein folding and enzyme activities prompted us to search for point mutations inside the E-domain, which should also lead to a specific loss of dehydrogenase function. Two invariant catalytic residues in the active site of the AroE homolog YdiB from E. coli, K71 and D107, had previously been identified as crucial for substrate binding (Lindner et al. 2005) . In the E-domain of S. cerevisiae Aro1, these residues are located at position 1370 and 1407, respectively. The K1370A mutation and a D1409A mutation have already been described in a previous study .
To test if the single amino acid exchanges cause a complete loss of the shikimate dehydrogenase function of Aro1, ARO1
K1370A
and ARO1 D1407A expressed under control of the strong constitutive HXT7 promoter were tested for their ability to complement the aromatic amino acid auxotrophy of the CEN.PK2-1C aroE strain. For this aim, a growth test was performed on media with or without the aromatic amino acids tyrosine and phenylalanine (Fig. 3A) . CEN.PK2-1C aroE and CEN.PK2-1C transformed with empty vector were used as controls. Both mutated ARO1 alleles were not able to complement the growth defect on media without tyrosine and phenylalanine, indicating a loss of shikimate dehydrogenase activity and making them suitable candidates for the CCM pathway.
To test the activity of the Aro1 variants, plasmids overexpressing ARO1 K1370A , ARO1 D1407A and ARO1 aroE were transformed into CEN.PK2-1C aroE. ARO3 K222L was overexpressed for increased substrate flux, and AroZ for production of PCA, which was determined after 96 h of incubation in selective SCD medium in the culture supernatant (Fig. 3B) 
Construction of an optimized production strain
In the next step, we decided to integrate the information gained in the previous experiments into the construction of a new production strain. ARO4 K229L , ARO3 K222L and ARO1 K1370A were combined on one plasmid under control of the strong constitutive TPI1, HXT7 and FBA1 promoters, respectively, using the backbone of 2μ plasmid pHD8 (Demeke et al. 2013 ) ( 3-DHS. Finally, stable genomic integration of the expression cassette allowed for the production of up to 482 mg L −1 3-DHS with strain JTY1 after incubation for 96 h. To improve the performance of the strain even further, a copy of the gene encoding transketolase 1 (TKL1) was integrated into the ZWF1 locus under control of the strong TDH3 promoter, thereby disrupting the glucose-6-phosphate dehydrogenase function of the gene. These manipulations force the entry of glycolytic intermediates into the non-oxidative part of the pentose phosphate cycle via the Tkl1 reaction, leading to enhanced supply of the shikimic acid precursor E4P (Curran et al. 2013) . Introducing these changes into strain JTY1 resulted in an improved titer of 3-DHS in the newly generated strain JTY4 (1552 mg L −1 ) compared to strain JTY1 (754 mg L −1 ) after 96 h (Fig. 4B) . The use of non-selective YEPD medium in this experiment might be responsible for the higher titer of 3-DHS in strain JTY1 compared to the titers achieved with the same strain in the previous experiment shown in Fig. 4A , where cells were grown in YEPD medium containing G418.
A novel PCA decarboxylase
In previous studies in S. cerevisiae (Weber et al. 2012; Curran et al. 2013; Skjoedt et al. 2016; Suastegui et al. , 2017 Leavitt et al. 2017 ) and E. coli (Draths and Frost 1994; Niu, Draths and Frost 2002; Sonoki et al. 2014; Zhang et al. 2015) , the bacterial decarboxylase AroY has been used for the conversion of PCA to catechol, which represents the limiting step in the heterologous CCM pathway. AroY-C, the enzyme with the actual decarboxylase function, requires the prenylated flavin mononucleotide (prFMN) cofactor for its activity, which is synthesized with the help of AroY subunit B (AroY-B) (Payer et al. 2017; Weber et al. 2017) . In bacterial genomes, AroY-C and -B are frequently encoded in the same operon together with subunit D (AroY-D), whose function is still unknown. Recently, a novel eukaryotic decarboxylase from the yeast Arxula adeninivorans, AGDC1, has been described (Meier et al. 2017) , which shows no homology to previously known bacterial PCA decarboxylases. The enzyme has been shown to accept GA and PCA as substrates. For comparison of their activities, AGDC1 and AroY from K. pneumoniae were expressed as codon optimized versions in a PCA feeding experiment in strain CEN.PK2-1C, whereby AGDC1 and AroY-C are under control of the strong, constitutive PGK1 promoter (Fig. 5) . All transformants were cultivated in selective SCD media containing 5 mM PCA for 144 hours. The pH of the medium supplemented with PCA is 4.3 at the start of the feeding experiment, corresponding to the pK a of 4.26 of the substance (Perrin and Sillen 1979) , and is dropping to pH 2.8 in the course of the experiment (not shown). Thus, sufficient amounts of the undissociated form of the acid should be taken up passively by the cell.
The results show that expression of AGDC1 from A. adeninivorans enhanced formation of catechol (140 mg L −1 ) compared to the expression of the bacterial enzyme AroY (109 mg L −1 ). To control that catechol is actually formed from PCA taken up by the cell and not from an intracellular source, we performed an experiment, where cells expressing AGDC1 were fed with distilled water or PCA (Fig. S1 , Supporting Information). Despite the presence of a functional decarboxylase, cells fed with water did not produce measurable amounts of catechol, proving that catechol produced by AGDC1 expressing cells is solely generated by conversion of externally added PCA. To find other related enzymes with a potentially higher activity, we performed a BLAST search with non-redundant protein sequences (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Our BLAST search revealed a plethora of sequences from diverse fungal species with identities of maximally 57% to AGDC1. For further analysis, we chose two proteins from Talaromyces atroroseus (Acc. No. XP 020118381.1; TaGDC1) and Madurella mycetomatis (Acc. No. KXX81388.1; MmGDC1) with 56% and 52% identity compared to AGDC1. Coding sequences for both proteins and AGDC1 were cloned in codon-optimized form under control of the strong, methionine-repressible MET25 promoter (Mumberg, Müller and Funk 1994) . Subsequently, PCA decarboxylase activities of both proteins were analyzed in comparison to AGDC1 in a feeding experiment with 5 mM PCA in strain CEN.PK2-1C (Fig. 6 ). Compared to AGDC1 expressing cells reaching a catechol titer of 460 mg L −1 , both other proteins turned out to have superior activity, with catechol titers of 619 mg L −1 (TaGDC1) and 584 mg L −1 (MmGDC1)
after 120 h cultivation in selective SCD medium lacking methionine. TaGDC1 was chosen for further experiments.
To test the performance of the new decarboxylase in optimized chassis strain JTY4 (Table 1) , the three enzymes of the heterologous CCM production pathway were combined on one plasmid under control of strong promoters. The production of CCM and the pathway intermediates 3-DHS, catechol and PCA was monitored in a fermentation starting with an OD 600 of 10 in selective SCD medium with 4% glucose over a period of 120 h (Fig. 7) . While CCM titers reached 1244 mg L −1 , intermediates 3-DHS and PCA still accumulated to levels of 2141 and 3063 mg L −1 , . cis, cis-Muconic acid production at high cells density in a batch fermentation. An expression plasmid encoding AroZ from Podospora anserina, GDC1 from Talaromyces atroroseus and CatA from Acinetobacter radioresistens (p423-H7-ArCatA, TaGDC1, PaAroZ) was transformed into yeast strain JTY4. Cells were inoculated to an OD600 of 10 from a preculture and cultivated in shake flasks for 120 h in selective synthetic complete (SCD) medium (4% glucose) at 30 • C. Samples from culture supernatants were taken at the indicated time points, and concentrations of 3-dehydroshikimate (3-DHS), protocatechuic acid (PCA) and cis, cis-muconic acid (CCM) were determined by HPLC. Error bars represent the standard deviation of three independent replicates, but are masked by the size of the symbols.
respectively. With 23 mg L −1 , catechol titers were negligible. To our knowledge, the yield of 31 mg g −1 glucose represents the so far highest yield of CCM obtained in S. cerevisiae.
GA production with the optimized chassis yeast strain
In the next step, we wanted to test the suitability of the JTY4 chassis strain for production of other aromatic compounds derived from 3-DHS. For this aim, we chose to introduce a pathway for production of GA, a compound with known antioxidant, anti-inflammative, antimutagenic and anticancer properties (Badhani, Sharma and Kakkar 2015) . A pathway for production of GA from 3-DHS via PCA was already established before in E. coli, making use of a mutant form of phydroxybenzoate hydroxylase PobA from Pseudomonas aeruginosa (Kambourakis, Draths and Frost 2000) . A conserved tyrosine 385 was replaced by phenylalanine (Y385F), changing substrate specificity and allowing for the enzyme to hydroxylate PCA to GA (Entsch et al. 1991; Eschrich et al. 1993) . The reaction requires O 2 and reduction equivalents. We created an analogous Y385F mutant of PobA from C. glutamicum (Huang et al. 2008 ) with the Gallic acid production at high cell density in a batch fermentation. Yeast strain JTY4 was transformed with expression plasmids p423-H7-PaAroZ and p425-H7-CgPobA Y385F . Cells were inoculated to an OD600 of 10 from a preculture and cultivated for 120 h at 30
• C in shake flasks in selective SCD medium (4% glucose). Culture supernatants were analyzed for production of 3-dehydroshikimate (3-DHS), protocatechuic acid (PCA) and GA using HPLC. Error bars represent the standard deviation of three independent replicates. ability to hydroxylate PCA to GA. NADPH is the preferred cofactor for the enzyme from C. glutamicum (Huang et al. 2008) . For production of GA in S. cerevisiae, wild-type pobA and the pobA Y385F mutant were expressed in strain JTY4 together with aroZ, and the formation of GA was determined after 120 h (Fig. 8A) . As anticipated, PobA Y385F produced much higher GA titers (298 mg L −1 ) than the wild-type enzyme (33 mg L −1 ). To boost the titer even more, we applied the conditions optimized for CCM production, as shown in Fig. 7 (Fig. 8B) . With a starting OD 600 of 10, strain JTY4 expressing aroZ and pobA Y385F from individual plasmids produced 682 mg L −1 of GA. Despite the relatively high titer of GA obtained under these conditions, activity of PobA Y385F is still limiting, as PCA accumulated to 6599 mg L −1 in the culture supernatant, probably due to NADPH limitations in the zwf1 deletion strain JTY4 (see discussion). Remarkably, the total amount of aromatic compounds analyzed (3-DHS, PCA and GA together) was higher than observed for production of CCM (3-DHS, PCA and CCM together) in Fig. 7 . Here, it has to be considered that different promoters were used in the two heterologous pathways (Table 2) , which might influence the flux through the upstream pathway. Differences in toxicities of the intermediates and products and in their secretion might be also responsible for this observation.
DISCUSSION
In the past years, several attempts have been made to optimize the production of CCM with yeast, which have led to considerable improvements in titers and yields (Curran et al. 2013; Skjoedt et al. 2016; Suastegui et al. , 2017 Leavitt et al. 2017) . Genetic manipulations and experimental conditions that have permitted these improvements are summarized in Table  S1 (Supporting Information). Nevertheless, the decarboxylation step from PCA to catechol still remains the main bottleneck of the pathway. In our study, we have created a strain with an optimized production of the shikimic acid pathway intermediate 3-DHS (Fig. 4) . In this strain, we have successfully utilized the recently identified eukaryotic PCA/GA decarboxylase AGDC1 (Meier et al. 2017) (Fig. 5) and two of its homologs from other organisms for production of CCM (Fig. 6 ). Using the same strain, we could demonstrate the production of GA from 3-DHS via PCA for the first time in S. cerevisiae (Fig. 8) .
In S. cerevisiae, the entrance reaction into the shikimic acid pathway is catalyzed by DAHP synthases Aro3 and Aro4. These highly homologous proteins are feedback regulated by aromatic amino acids phenylalanine and tyrosine, respectively (Braus 1991) . With lower K m values for E4P and PEP and a higher K i for its specific inhibitor (Hartmann et al. 2003) , Aro3 can be regarded as the more effective enzyme. Nonetheless, so far only feedbackresistant mutants of Aro4 have been utilized in metabolic engineering applications (Curran et al. 2013; McKenna et al. 2014; Li et al. 2015; Rodriguez et al. 2015; . We have introduced an analogous mutation to the K229L exchange in the effector binding cavity of Aro4 into Aro3 (Hartmann et al. 2003) , generating Aro3 K222L . Overexpressed together with Aro4 K229L , the flux into the shikimic acid pathway could be considerably improved compared to the individual mutants (Fig. 2) . Nevertheless, we cannot exclude an additional positive effect due to the simultaneous codon optimization of Aro3 K222L . The next steps in the shikimic acid pathway are catalyzed by the multifunctional Aro1 protein.
To block further conversion of 3-DHS to aromatic amino acids, the dehydrogenase domain E had been completely deleted in a previous study (Weber et al. 2012) . Here, we could show (i) that in general overexpression of ARO1 mutant versions without dehydrogenase activity is beneficial for 3-DHS and PCA production but (ii) that even higher product titers could be achieved by implementing an Aro1 D1370A mutant with a point mutation in the E-domain, a mutation that is presumably less detrimental for the overall structure and activity of Aro1 than a deletion of the whole E-domain (Fig. 3) . The deletion of the ZWF1 gene encoding glucose-6-phosphate dehydrogenase ZWF1 in combination with an overexpression of TKL1 has already been described to lead to an enhanced production of CCM (Curran et al. 2013) , an effect that was not observed consistently in a more recent study in a different strain background (Suastegui et al. 2017 ). In our study, an integration of an overexpression construct for TKL1 combined with the deletion of ZWF1 in a aroE strain already harboring integrations of overexpression constructs for ARO3 K222L , ARO4 K229L and ARO1 K1370A led to a 2.1-fold enhancement in the formation of 3-DHS (Fig. 4B) , and after integration of the complete CCM pathway allowed for a final titer of 1244 mg L −1 of CCM (Fig. 7) . Glucose-6-phosphate dehydrogenase is the major source of cytosolic NADPH, and a deletion of the corresponding gene has been shown to cause defects in NADPH-requiring processes, such as assimiliation of sulfur, leading to a requirement for an organic sulfur source, such as methionine or cysteine (Thomas, Cherest and Surdin-Kerjan 1991) . If such a deficiency in NADPH supply would lead to an impairment in growth, it would make a strain unattractive in industrial applications. Growth of the zwf1 strain JTY4 was not impaired in YEPD medium. Nevertheless, upon cultivation in SCD medium lacking methionine growth was slightly impaired and CCM titers were reduced, although growth tests revealed that the strain was not completely auxotrophic for methionine (not shown). Moreover, in a previous report about shikimic acid production, which involves the NADPH-dependent shikimic acid dehydrogenase, a deletion of ZWF1 led to an enhanced accumulation of 3-DHS and a reduced level of the desired product shikimic acid, indicating a reduced activity of the NADPH-dependent shikimate dehydrogenase function of Aro1 (Suastegui et al. 2017) . Thus, if NADPH demands are high, especially due to the implementation of NADPH requiring reactions, limitations in product titers can be expected. Other cytosolic sources for NADPH exist, which could compensate for the deficiency. It has been shown that the cytosolic aldehyde dehydrogenase Ald6 can partially compensate for the reduced NADPH/NADP ratio in yeast cells with a deletion in ZWF1 (Grabowska and Chelstowska 2003) . Isocitrate dehydrogenase (Idp2) is another source for cytosolic NADPH when glucose is exhausted (Minard and McAlister-Henn 2005) . In our study about GA production, we also used the zwf1 deletion strain JTY4. The heterologous enzyme CgPobA prefers NADPH over NADH as a cofactor (Huang et al. 2008 ). Although we could achieve GA titers up to 682 mg L −1 (Fig. 8) , the intermediate PCA still accumulated to very high amounts, which might be indicative for NADPH limitations. Other bacterial homologous with a preference for NADH exist, which could be used alternatively for the conversion of PCA to GA (Fujii and Kaneda 1985; Jadan et al. 2001; Iwaki et al. 2005) . In addition to the replacement of NADPH with NADH consuming reactions (Brochado et al. 2010) , implementing transhydrogenases converting NADH to NADPH (Fiaux et al. 2003) or establishing NADPH generating reactions (Verho et al. 2002) might be valuable strategies to broaden the applicability of a zwf1 strain. Moreover, as also the catalytic activity of PobA might be limiting, mutant forms could be used, such as the combined mutations of T294A and Y385F. The T294A mutation, which is located in the catalytic pocket of the enzyme, has recently been described to improve the hydrogen-bond mediated interaction between PobA Y385F and PCA, thereby enhancing the catalytic activity of P. aeruginosa PobA Y385F (Chen et al. 2017) . The eukaryotic decarboxylase AGDC1 has been described to be specific not only for PCA, but also for GA (Meier et al. 2017) . Engineering the specificity of AGDC1 could allow for the extension of our newly implemented pathway, enabling the production of pyrogallol, a compound with applications in the pharmaceutical and chemical industry (Kambourakis, Draths and Frost 2000) . For the production of CCM, the eukaryotic enzyme AGDC1 exhibits several advantages over its prokaryotic AroY analog. The decarboxylase function of AroY is performed by subunit C and requires the cofactor prenylated flavin mononucleotide (prFMN), which is synthesized by AroY-B. prFMN can be synthesized with the help of the endogenous yeast enzyme Pad1, but this enzyme is absent in some yeast strains, such as the strain CEN.PK2-1C used in this study (Weber et al. 2017) . Even though AroY-C iso from K. pneumoniae showed reduced oxygen sensitivity compared to other C subunits tested (Weber et al. 2012) , the enzyme showed only full activity upon cultivation of the host strain under oxygen-limited conditions ). In contrast to AroY (Weber et al. 2017) , AGDC1 and its homologs show high activity in strain CEN.PK2-1C (Figs 5 and 6 ) without the requirement to express an additional cofactor generating enzyme, reducing the metabolic burden imposed on the production organism. Moreover, a fine-tuning of expression of the decarboxylase and the cofactor generating enzyme can be omitted. Despite all these advantages and the titer of 1244 mg L −1 CCM achieved with the new enzyme, the decarboxylase substrate PCA still accumulates to 3063 mg L −1 , still indicating a major limitation. However, the requirement for only one enzyme will certainly ease multiple integrations of the enzyme or enzyme engineering, which will be needed to overcome the bottleneck.
In conclusion, although just applying a few rational design strategies in combination with a novel enzyme has led to production of a significant yield of CCM, for an industrial process these must be still improved. Novel high-throughput systems utilizing biosensors (Skjoedt et al. 2016; Leavitt et al. 2017) in combination with adaptive laboratory evolution strategies have a high potential to identify new targets for further manipulations, which might finally allow for an industrial application of yeast for CCM and GA production.
